NCT05313516

Brief Summary

The purpose of this study is to determine the feasibility of the OKKO Space Academy app as a vision measuring and home-monitoring tool for children aged 3-8 years undergoing amblyopia treatment. There are three objectives to this work:

  1. 1.Determine the feasibility of the OKKO Space Academy app for use between clinic visits from the child's and family perspective (i.e., acceptability, usability and engagement).
  2. 2.Assess the variability in day-to-day OKKO Health measurements between clinic visits (e.g., do the interim OKKO home vision measurements predict improvements in visual acuity?)
  3. 3.Explore agreement between the OKKO Space Academy measures of visual acuity against in-clinic measurements (usual standard of care), including an exploration of intra- and inter-session repeatability.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 6, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

June 26, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

December 1, 2023

Status Verified

November 1, 2023

Enrollment Period

1.8 years

First QC Date

December 1, 2021

Last Update Submit

November 30, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Feasibility and acceptability of home monitoring using the OKKO Health app

    The feasibility and acceptability of the OKKO Space Academy app for use between clinic visits from the child's and family perspective. This will be assessed through a purpose built questionnaire.

    3 months

  • Engagement of home monitoring using the OKKO Health app

    The rate of engagement with the OKKO Space Academy app for use between clinic visits by the child (patient) and the family.

    3 months

  • Variability in app data.

    The variability in day-to-day OKKO Health measurements between clinic visits (e.g., do the interim OKKO home vision measurements predict changes in visual acuity?)

    3 months

  • Visual acuity

    Exploring the agreement between the OKKO Space Academy measures of visual acuity against in-clinic measurements (usual standard of care), including an exploration of intra- and inter-session repeatability.

    3 months

Study Arms (1)

OKKO Health app

EXPERIMENTAL

Use of OKKO Health app for home monitoring.

Device: OKKO Health app

Interventions

Use of OKKO Health app for home monitoring.

OKKO Health app

Eligibility Criteria

Age3 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 3.01 - 8.99 years with amblyopia
  • Currently undergoing or at first visit to start amblyopia patching treatment
  • Vision is fully corrected in glasses
  • Visual acuity between -0.02 and 0.98 logMAR
  • Have daily access to an approved smartphone or tablet
  • Parent/child able to read and understand English
  • Patient (child) able to understand spoken English

You may not qualify if:

  • Parent not able to read and understand English
  • Patient (child) not able to understand spoken English
  • Parent/child not willing to participate
  • Parent unable to give consent
  • Any other ocular comorbidities
  • Child has cognitive impairment or intellectual disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moorfields Eye Hospital

London, United Kingdom

Location

MeSH Terms

Conditions

Amblyopia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2021

First Posted

April 6, 2022

Study Start

June 26, 2022

Primary Completion

March 31, 2024

Study Completion

June 30, 2024

Last Updated

December 1, 2023

Record last verified: 2023-11

Locations